Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?

Georgios Pongas,Russell E. Lewis,Russell E. Lewis,G. Samonis,D. Kontoyiannis,D. Kontoyiannis
DOI: https://doi.org/10.1111/j.1469-0691.2009.02988.x
IF: 13.31
Clinical Microbiology and Infection
Abstract:Mucormycosis (zygomycosis) is an uncommon infection that afflicts severely immunocompromised patients and those with poorly controlled diabetes mellitus. A recent increase in the incidence of mucormycosis at many transplant centres has been linked to the introduction and widespread use of voriconazole prophylaxis in these high-risk populations. However, it is not known if this association reflects a true epidemiological link or represents a marker of changing immunosuppression occurring in parallel with the evolution of transplant practices and immunosuppression strategies.
What problem does this paper attempt to address?